Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]

NCT03265145 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

714

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Stiolto Respimat
DRUG: ICS (Inhaled Corticosteroid) (Triple therapy)
DRUG: LABA (Long-Acting Beta Agonist) (Triple therapy)
DRUG: LAMA (Long-Acting Muscarinic Antagonist) (Triple therapy)

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]